Tricida Secures $55,000,000 Series C Financing
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9db2a841-f3ec-4516-b855-08895a36d199 - Date
7/26/2016 - Company Name
Tricida - Mailing Address
7000 Shoreline Court South San Francisco, CA 94080 USA - Company Description
Tricida, Inc. is an innovative startup company focused on the discovery and clinical development of novel therapeutics to address renal, metabolic and cardiovascular disease. - Website
http://www.tricida.com - Transaction Type
Venture Equity - Transaction Amount
$55,000,000 - Transaction Round
Series C - Proceeds Purposes
The financing round will enable late-stage trials of first-in-class clinical candidate TRC101 in patients with kidney disease. - M&A Terms
- Venture Investor
Longitude Capital Management - Venture Investor
Vivo Capital - Venture Investor
OrbiMed - Venture Investor
Limulus Venture Partners - Venture Investor
Sibling Capital Ventures
